Jacobi Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Jacobi Capital Management's NEO Position: Q4 2021 in Review
Jacobi Capital Management sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 2,000 shares — an estimated $96K sold.
Jacobi Capital Management first reported a position in NEO in Q2 2016 and held it in 22 quarters. The position peaked at $108K in Q4 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.
- Jacobi Capital Management reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
- Jacobi Capital Management sold 2,000 NeoGenomics shares in Q4 2021, an estimated $96K.
- Jacobi Capital Management first reported a position in NeoGenomics in Q2 2016 and held it in 22 quarters.
- Jacobi Capital Management's NeoGenomics position peaked at $108K in Q4 2020.
- 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.
Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.